Kontrollert frisetting av AMC-109 fra medicinskt utstyr

Offentlig prosjektsammendrag

Healthcare associated infections related to medical devices is a risk and cause of suffring to patients, increases cost of care and increases the spread of antibiotic resistance. To adress these issues Amicoat incorporates it's proprietary technology into medical device materials. In this project Amicoat will expand our knowledge by focusing on 3 major medical device material types, i.e. porous materials, bulk materials and coatings. The goal for this project is to research how our antimicrobial peptide (AMC-109) may be introduced into such materials in an industrially scalable fashion and how release of AMC-109 may be tailord to acheive the desired antimicrobial and other device specific properties for different applications. This will enable Amicoat to attract more customers, grow the company and reduce the rate of hospital acquried infeactions.